PTC Therapeutics
PTCT
#2687
Rank
NZ$10.73 B
Marketcap
NZ$133.73
Share price
-0.76%
Change (1 day)
62.53%
Change (1 year)

Revenue for PTC Therapeutics (PTCT)

Revenue in 2025 (TTM): NZ$3.10 Billion

According to PTC Therapeutics 's latest financial reports the company's current revenue (TTM ) is NZ$3.07 Billion. In 2024 the company made a revenue of NZ$1.43 Billion a decrease over the revenue in the year 2023 that were of NZ$1.48 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for PTC Therapeutics from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$3.10 B117.38%
2024 NZ$1.43 B-3.54%
2023 NZ$1.48 B34.74%
2022 NZ$1.10 B39.58%
2021 NZ$0.78 B49.42%
2020 NZ$0.52 B15.77%
2019 NZ$0.45 B15.49%
2018 NZ$0.39 B44.19%
2017 NZ$0.27 B129.25%
2016 NZ$0.11 B108.2%
2015 NZ$57.34 M95.66%
2014 NZ$29.3 M-23.11%
2013 NZ$38.12 M8.97%
2012 NZ$34.98 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Vertex Pharmaceuticals
VRTX
NZ$20.29 B 558.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$4.17 B 35.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$12.35 M-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
NZ$36.12 M-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.28 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$97.57 B 3,068.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland